Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa peritonitis in a murine model

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1609-1615

  Barekzi, Nazir A ^a   Poelstra, Kornelis A ^a   Felts, Adrian G ^a   Rojas, Ignacio A ^a   Slunt, Jeffrey B ^b   Grainger, David W ^b  

^a Medical Sciences Research Institute   (United States)

^b GAMMA A Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G; INTERLEUKIN 6; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL COUNT; BACTERIAL PERITONITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN CELL; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OPSONIZATION; POPULATION RISK; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032803960     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1609     Document Type: Article

References (47)

1. Barriere, S. L., and B. J. Guglielmo. 1992. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Clin. Pharmacol. 11:223-235.
2. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
3. Bodey, G. P., L. Jadeja, and L. Elting. 1985. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch. Intern. Med. 145:1621-1629.
4. Calandra, T., J. Gerain, D. Heumann, J.-D. Baumgartner, and M. P. Glauser. 1991. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am. J. Med. 91:23-29.
5. Clapp, D. W., R. M. Kliegman, J. E. Baley, N. Shenker, K. Kyllonen, A. A. Fanaroff, and M. Berger. 1989. Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study. J. Pediatr. 115:973-978.
6. Cross, A. S. 1995. Intravenous immunoglobulins (IVIGS) to prevent and treat infectious diseases, p. 123-131. In M. Z. Attazi and G. S. Bixler, Jr. (ed.), Immunobiology of proteins and peptides, vol. VIII. Plenum Press, Inc., New York, N.Y.
7. Donta, S. T., P. Peduzzi, A. S. Cross, J. Sadoff, C. Haakenson, S. J. Cryz, C. Kauffman, S. Bradley, G. Gafford, D. Elliston, T. R. Beam, J. F. John, B. Ribner, R. Cantey, C. H. Welsh, R. T. Elliston III, E. J. Young, R. J. Hamill, H. Leaf, R. M. H. Shein, M. Mulligan, C. Johnson, E. Abrutyn, J. M. Griffiss, R. Hamadeh, A. H. Eliasson, J. B. McClain, G. P. Melcher, J. W. Kelly, W. R. Byrne, M. Wallace, D. Amundson, B. Gumpert, and D. Slagle. 1991. Immunoprophylaxis against Kleibsiella and Pseudomonas aeruginosa infections. J. Infect. Dis. 174:537-543.
8. Fabian, T. C. 1993. Prevention of infections following penetrating abdominal trauma. Am. J. Surg. 165:14S-19S.
9. Falagas, M. E., L. Barefoot, J. Griffith, R. Ruthazar, and D. R. Snydman. 1996. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur. J. Clin. Microbiol. Infect. Dis. 15:913-921.
10. Felts, A. G., G. Giridhar, D. W. Grainger, and J. B. Slunt. 1999. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model. Burns 25:415-423.
11. Fischer, G. W., T. J. Cieslak, S. R. Wilson, L. E. Weisman, and V. G. Hemming. 1994. Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin. J. Infect. Dis. 169:324-329.
12. Fomsgaard, A., and I. A. Holder. 1993. Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice. APMIS 101:229-234.
13. Gristina, A. G. 1985. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237:1588-1595.
14. Gristina, A. G., P. Naylor, and Q. Myrvik. 1989. Infections from biomaterials and implants: a race for the surface. Med. Prog. Technol. 14:205-224.
15. Haissam, S. E., A. K. Chopra, J. W. Peterson, R. Goodheart, and J. P. Heggers. 1998. Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A. Infect. Immun. 66:2170-2179.
16. Haissam, S. E., A. K. Chopra, J. W. Peterson, M. L. Vasil, and J. P. Heggers. 1998. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies. Infect. Immun. 66:5551-5553.
17. Hammarström, L., and C. I. E. Smith. 1990. The use of intravenous IgG as prophylaxis and for the treatment of infections. Infection 18:314-324.
18. Hiemstra, P. S., J. Brands-Tajouiti, and R. van Furth. 1994. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay. J. Lab. Clin. Med. 123:241-246.
19. Holder, I. A. 1988. Pseudomonas immunotherapy. Serodiagn. Immunother. 2:7-16.
20. Holmes, C. J. 1994. Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int. 46(Suppl. 48):S58-S70.
21. Johnson, C. C., J. Baldessarre, and M. E. Levison. 1997. Peritonitis: update on pathophysiology, clinical manifestations, and management. Clin. Infect. Dis. 24:1035-1047.
22. Keane, W. F., and P. K. Peterson. 1984. Host defense mechanisms of the peritoneal cavity and continuous ambulatory peritoneal dialysis. Peritoneal Dial. Bull. 4:122-127.
23. Keane, W. F., C. M. Comty, H. A. Verbrugh, and P. K. Peterson. 1984. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int. 25:539-543.
24. Kovacs, K., D. L. Paterson, and V. L. Yu. 1998. Antimicrobial therapy for Pseudomonas aeruginosa: therapeutic issues; resistance; pneumonia; endocarditis; and infections of the GI tract, bone and joint, and urinary tract. Infect. Med. 15:385-394.
25. Lamperi, S., and S. Carozzi. 1986. Defective opsonic activity of peritoneal effluent during continuous ambulatory peritoneal dialysis (CAPD): importance and prevention. Peritoneal Dial. Bull. 6:87-92.
26. Lamperi, S., S. Carozzi, and M. G. Nasini. 1986. Intraperitoneal immunoglobulin (Ig) treatment in prophylaxis of bacterial peritonitis in CAPD. Peritoneal Dial. Bull. 6:110-113.
27. Leake, E. S., M. J. Wright, and A. S. Kreger. 1978. In vitro effect of purified proteases of Pseudomonas aeruginosa on rabbit lung macrophages. Exp. Mol. Pathol. 29:241-252.
28. Levison, M. E., and L. M. Bush. 1995. Peritonitis and other intra-abdominal infections, p. 705-740. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, Inc., New York, N.Y.
29. Magny, J.-F., C. Bremard-Oury, D. Brault, C. Menguy, M. Voyer, P. Landais, M. Dehan, and J.-C. Gabilan. 1991. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature infants: report of a multicenter, double blind study. Pediatrics 88:437-443.
30. Montie, T. C., R. C. Craven, and I. A. Holder. 1982. Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect. Immun. 35:281-288.
31. Neely, A. N., D. L. Hoover, I. A. Holder, and A. S. Cross. 1996. Circulating levels of tumour necrosis factor interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns 22:524-530.
32. Neely, A. N., I. A. Holder, J. W. Larrick, and L.-T. Chong. 1990. Comparison of pre- versus post-sepsis treatment with polyclonal immunoglobulin versus O serotype-specific monoclonal antibody in burned Pseudomonas aeruginosa infected mice. Serodiagn. Immunother. 4:221-230.
33. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
34. Nyström, P.-O., R. Bax, E. P. Dellinger, L. Dominioni, W. A. Knaus, J. L. Meakins, C. Ohmann, J. S. Solomkin, H. Wacha, and D. H. Wittman. 1990. Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection. World J. Surg. 14:148-158.
35. Ochi, H., H. Ohtsuka, S.-I. Yokota, I. Uezumi, M. Terashima, K. Irie, and H. Noguchi. 1991. Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa. Infect. Immun. 59:550-554.
36. Prescott, L. M., J. P. Harley, and D. A. Klein. 1993. Human diseases caused by other bacteria (chlamydiae, mycoplasmas, rickettsias); dental and nosocomial infections, p. 770-780. In K. Kane (ed.), Microbiology, 2nd ed. William C. Brown Publishers, Dubuque, Iowa.
37. Rojas, I. A., G. G. Anderson, D. W. Grainger, and J. B. Slunt. Inhibition of flagellated bacteria motility in vitro using pooled human polyclonal immunoglobulin. Submitted for publication.
38. Rubin, J., W. A. Rogers, H. M. Taylor, E. D. Everett, B. F. Prowant, L. V. Fruto, and K. D. Nolph. 1980. Peritonitis during continuous ambulatory peritoneal dialysis. Ann. Intern. Med. 92:7-13.
39. Saklayen, M. G. 1990. CAPD peritonitis: incidence, pathogens, diagnosis, and management. Med. Clin. N. Am. 74:997-1010.
40. Shein, M., D. H. Wittmann, R. Holzheimer, and R. E. Condon. 1996. Hypothesis: compartmentalization of cytokines in intra-abdominal infection. Surgery 119:694-700.
41. Sheridan, R. L., R. G. Tompkins, and J. F. Burke. 1994. Prophylactic antibiotics and their role in the prevention of surgical wound infection. Adv. Surg. 27:43-57.
42. Siber, G. R. 1992. Immunoglobulin to prevent nosocomial infections. N. Engl. J. Med. 327:269-271.
43. Siber, G. R., and D. R. Snydman. 1992. Use of immune globulins in the prevention and treatment of infections, p. 208-252. In J. S. Remington and M. N. Schwartz (ed.), Current clinical topics in infectious disease. Blackwell Scientific, Boston, Mass.
44. Slingeneyer, A., C. Mion, J. J. Beraud, R. Oules, B. Branger, and M. Balmes. 1981. Peritonitis, a frequently lethal complication of intermittent and continuous ambulatory peritoneal dialysis. Proc. Eur. Dial. Transplant Assoc. 18:212-221.
45. Smith, J. A. 1991. Treatment of intra-abdominal infections with quinolones. Eur. J. Clin. Microbiol. Infect. Dis. 10:330-333.
46. Tyau, E. S., J. B. Prystowsky, R. J. Joehl, and D. L. Nahrwold. 1991. Acute diverticulitis. Arch. Surg. 126:855-859.
47. Yao, L., J. W. Berman, S. M. Factor, and F. D. Lowy. 1997. Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection. Infect. Immun. 65:3889-3895.